According to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), mood disorders are a key comorbidity in patients with psoriatic arthritis. How often do you screen for...
According to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), mood disorders are a key comorbidity in patients with psoriatic arthritis. How often do you screen for...
According to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), mood disorders are a key comorbidity in patients with psoriatic arthritis. How often do you screen for...
According to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), mood disorders are a key comorbidity in patients with psoriatic arthritis. How often do you screen for...
According to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), mood disorders are a key comorbidity in patients with psoriatic arthritis. How often do you screen for...
According to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), mood disorders are a key comorbidity in patients with psoriatic arthritis. How often do you screen for...
Do you think deep brain stimulation or botulinum toxin is more effective for the treatment of patients with primary dystonia? Let us know by taking our poll.
It has been debated whether single- vs dual-hormone artificial pancreas systems are better for patients with type 2 diabetes mellitus. Tell us what you think via our latest poll.
It has been debated whether single- vs dual-hormone artificial pancreas systems are better for patients with type 2 diabetes mellitus. Tell us what you think via our latest poll.
It has been debated whether single- vs dual-hormone artificial pancreas systems are better for patients with type 2 diabetes mellitus. Tell us what you think via our latest poll.
